Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir

Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir

Bibliographic Details
Main Authors: Yu Bai, Fei Ye, Yong Feng, Hanyi Liao, Hao Song, Jianxun Qi, George Fu Gao, Wenjie Tan, Lifeng Fu, Yi Shi
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-021-00468-9

Internet

https://doi.org/10.1038/s41392-021-00468-9

Similar Items